MicroRNA signatures in cytopathology: Are they ready for prime time?

In this issue of Cancer Cytopathology, Mancuso et al evaluate the use of a defined microRNA signature as a prognostic factor in small cell lung cancer. This editorial briefly comments on their article and shares views on the use of microRNA panels in contemporary practice in cytopathology.See also pages 000‐000.

Source: Cancer Cytopathology - March 31, 2016 Category: Pathology Authors: Francisco Beca, Fernando Schmitt Tags: Editorial Source Type: research